CMDN Icon
CMDNChina Myeloma Digital Network

Multiple Myeloma Clinical Guidelines
You never fight alone — we guide every step

Multiple myeloma is now a highly manageable condition.Hope and breakthroughs are always within reach.

Strictly distilled from authoritative guidelines
NCCNIMFMMRF
IMWGEMNmSMART
👇 Please select your current stage

Take a deep breath. Multiple Myeloma is increasingly becoming a manageable chronic condition. Focus on taking the right next steps with confidence.

Essential Knowledge for This Stage

What is Multiple Myeloma?

Understanding the basics of plasma cells and CRAB criteria.

"Myeloma is a treatable cancer, and incredible advances have transformed it into a highly manageable disease."

Can Multiple Myeloma Be Cured?

Understanding the 2026 Functional Cure paradigm, sustained MRD negativity, and latest trial breakthroughs.

"With anti-CD38 quadruplets, ASCT, CAR-T, and bispecific antibodies, patients are increasingly stepping toward functional curability."

Frontline Treatment Playbook

Four-drug quadruplets, fitness evaluation, and tailored induction pathways.

"Frontline therapy is your single best window of opportunity to achieve deep, durable clearance."

How do I read my lab reports?

A beginner's guide to SPEP, UPEP, and bone marrow biopsy results.

"Understanding the M-spike and free light chains is your first step to tracking your own progress."

Am I high-risk or standard-risk?

Decoding your FISH test and cytogenetics.

"High-risk does not mean hopeless; it simply means your doctor will use stronger, more targeted tools."

Understanding Myeloma Stages

How ISS, R-ISS, and R2-ISS evaluate risk and why Stage III is not terminal.

"Stage III in multiple myeloma simply reflects higher blood markers—it does not mean metastatic or untreatable cancer."

How do I cope emotionally?

Managing fear, building support, and taking back control.

"Acknowledging your fear is normal. Connecting with a support group can significantly improve your treatment journey."

Frontline Trials in China

Enrollment windows, quadruplet regimens, and eligibility in China.

"The frontline trial window is strictly time-sensitive and permanently closes after full-course chemo begins."

Knowledge Atlas Index

Quickly find all required clinical information by category.

Diagnosis & Monitoring8 Topics

From lab reports to MRD

What is Multiple Myeloma?

Understanding the basics of plasma cells and CRAB criteria.

How do I read my lab reports?

A beginner's guide to SPEP, UPEP, and bone marrow biopsy results.

Am I high-risk or standard-risk?

Decoding your FISH test and cytogenetics.

Risk Re-Evaluation at Relapse

How cytogenetic shifts and R2-ISS scores guide next-line precision therapy.

Tracking the M-Protein

How SPEP and UPEP track the return of myeloma.

Do I need another biopsy?

Why repeating the bone marrow biopsy is crucial at relapse.

Which scans are best?

The role of PET-CT and MRI in detecting active disease.

What is MRD Negative?

Understanding Minimal Residual Disease testing.

Sincere thanks to the following authoritative institutionsfor their academic support:
NCCNIMFMMRF
IMWGEMNmSMART
Lighting the hope of survivalfor myeloma patients globally
Disclaimer: All disease knowledge, guideline interpretations, and treatment processes provided on this site are for learning and reference only, and do not constitute any medical advice or professional diagnosis. The condition of each patient is unique. For specific treatment plans and medication decisions, please be sure to follow the guidance of your attending physician or professional medical team.
Get Support